HomeTagsKRAZATI

KRAZATI

Biotechnology

Journal of Clinical Oncology Publishes Rapid Communication Featuring Updated Clinical Data for Adagrasib as a Targeted Treatment for KRASG12C-Mutated Advanced Solid Tumors

PR Newswire - April 28, 2023

Mirati Therapeutics, Inc., a commercial stage biotechnology company, announced the Journal of Clinical Oncology published in a Rapid Communication data indicating adagrasib, a potent and selective...

Healthcare

KRAZATI Now Available from Onco360 for the Treatment of Adult Patients

Business Wire - December 19, 2022

Onco360, the nation’s leading independent Specialty Pharmacy, has been selected by Mirati Therapeutics to be a specialty pharmacy partner for KRAZATI, which is an...